Beckman Coulter Selects Axeda Device Relationship Management System for High-Volume Hematology Analyzers.Business/Technology Editors FULLERTON, Calif. & MANSFIELD, Mass.--(BUSINESS WIRE)--March 4, 2002 Axeda's DRM (1) (Digital Radio Mondiale) A digital audio broadcasting (DAB) system for AM radio in Europe. See HD Radio. (2) (Digital Rights M System Now Increases Remote Monitoring (protocol) remote monitoring - (RMON) A network management protocol that allows network information to be gathered at a single computer. Whereas SNMP gathers network data from a single type of Management Information Base (MIB), RMON 1 defines nine additional MIBs that provide a , Troubleshooting Capabilities for Two Beckman Coulter This article needs sources or references that appear in reliable, third-party publications. Alone, primary sources and sources affiliated with the subject of this article are not sufficient for an accurate encyclopedia article. Platforms for Improved Instrument Uptime Axeda Systems Inc. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on : XEDA), a provider of Device Relationship Management (DRM) software and services, today announced that Beckman Coulter, Inc. (NYSE NYSE See: New York Stock Exchange : BEC) has chosen to employ the Axeda DRMTM system on its COULTER(R)LH 700 hematology line, a series of high-volume analyzers used by diagnostic laboratories to perform routine and emergency blood cell counts blood cell count, n an estimation of the number and types of circulating blood cells (e.g., red blood cells [erythrocytic series], white blood cells, differential). . The Axeda DRM system enables Web transmission of instrument data - such as temperature, voltage, calibration and other events - and alerts service representatives if an instrument is operating outside preset preset Cardiac pacing A parameter of a pacemaker that is programmed permanently when manufactured performance standards, which can indicate a potential problem and result in equipment downtime. Beckman Coulter will incorporate the technology as part of its PROService program, the company's automated monitoring and proactive troubleshooting service for increased instrument uptime. "Beckman Coulter is rated number one in overall manufacturer satisfaction in terms of hematology service by hospital laboratories, and now our service program is even better," said Denny Kershner, Beckman Coulter director of marketing. "The Axeda system increases our abilities to monitor events and troubleshoot potential problems. Customers enrolled in our PROService program will benefit from improved instrument uptime and performance, while Beckman Coulter will benefit from access to critical performance information in real-time, which enables us to lower our costs by reducing the number of unscheduled unscheduled Adjective not planned or intended Adj. 1. unscheduled - not scheduled or not on a regular schedule; "an unscheduled meeting"; "the plane made an unscheduled stop at Gander for refueling" service visits." This is the second application by Beckman Coulter of the Axeda DRM system. In July 2001, the company began implementing the Axeda DRM system on its SYNCHRON LX(R) clinical systems, one of the most widely placed chemistry analyzers in U.S. hospitals. The positive results of the DRM implementation on the chemistry system led Beckman Coulter to adopt the Axeda DRM system for use on its LH 700 series hematology instruments. "Beckman Coulter is an innovator in remote diagnostic solutions and recognizes the benefits that Device Relationship Management technology brings to its offerings," said Paul Henderson
Paul Henderson (born January 28, 1943 in Lucknow, Ontario, Canada) is a retired Canadian hockey left winger who played 13 , Axeda vice president of marketing. "We are delighted with this expansion of our relationship. We share a common vision and together we will enable leading-edge, proactive services that achieve maximum responsiveness and result in the highest levels of customer satisfaction." About Axeda Formed from the union of eMation and RAVISENT Technologies, Axeda Systems Inc. (NASDAQ: XEDA) is an enterprise software and services company that helps businesses become more competitive by using the Internet to tap the value of real time information to optimize their service, development, sales and manufacturing operations Manufacturing operations concern the operation of a facility, as opposed to maintenance, supply and distribution, health, and safety, emergency response, human resources, security, information technology and other infrastructural support organizations. . The company's flagship Axeda Device Relationship Management System is a distributed software solution that lets businesses monitor, manage and service intelligent devices deployed at remote sites. Axeda serves Global 2000 companies in multiple markets including Industrial and Building Automation, Technology, Medical Instrumentation, Office and Semiconductor Equipment industries through sales and service offices in the U.S., Europe, Israel and Japan, and distribution partners worldwide. More information about Axeda is available at www.axeda.com. About Device Relationship Management The intelligent devices that we see and interact with everyday such as copiers, elevators, vending machines, building control units, medical devices, and even automobiles represent an important new source of business information. To date most enterprises have not been able to tap this information. Device Relationship Management addresses this significant information blind spot by providing a distributed information management system that leverages the Internet, allowing timely, accurate, and unbiased information to be communicated automatically between remote devices deployed at customer facilities and external service personnel or enterprise business systems. Device Relationship Management helps turn reactive businesses into proactive businesses providing new sources of revenue and increased operational efficiency at lower costs with an ROI (Return On Investment) The monetary benefits derived from having spent money on developing or revising a system. In the IT world, there are more ways to compute ROI than Carter has liver pills (and for those of you who never heard of that expression, it means a lot). that can often be measured in months. About Beckman Coulter Beckman Coulter, Inc. is a global biomedical bi·o·med·i·cal adj. 1. Of or relating to biomedicine. 2. Of, relating to, or involving biological, medical, and physical sciences. company headquartered in Fullerton, Calif. The company develops and markets instruments, chemistries, software and supplies that simplify and automate laboratory processes throughout the biomedical testing biomedical test A test intended to evaluate qualitative or quantitative derangements in physiology and predict impaired health due to exposure to hazardous materials continuum. Through pioneering medical research and drug discovery, specialty testing, and patient care diagnostics, Beckman Coulter supports all phases of the battle against disease. Annual sales for the company totaled $2 billion in 2001, with 62 percent of this amount generated by recurring revenue from supplies, chemistry kits and services. For more information, visit www.beckmancoulter.com. (c)2002 Axeda Systems. All rights reserved. Axeda and Axeda Systems trademarks of Axeda Systems Inc. COULTER and SYNCHRON LX are trademarks of Beckman Coulter, Inc. All other trademarks are property of their respective owners. This press release may contain certain forward-looking statements that relate to Axeda's future performance. Such statements are subject to a number of risks and uncertainties that may cause the actual events of future results to differ from those discussed herein. Such factors include, among others: uncertainties in the market for DRM products; the long sales cycle for DRM products; limited distribution channels; the difficulty of protecting proprietary rights; present and future competition; and Axeda's ability to manage technological change and respond to evolving industry standards. Investors are advised to read Axeda's (formerly Ravisent Technologies Inc.'s) Annual Report on Form 10-K Form 10-K A report required by the SEC from exchange-listed companies that provides for annual disclosure of certain financial information. Form 10-K See 10-K. and quarterly reports on Form 10-Q Form 10-Q See 10-Q. and Forms 8-K and the company's proxy statement Proxy Statement A document containing the information that a company is required by the SEC to provide to shareholders so they can make informed decisions about matters that will be brought up at an annual stockholder meeting. filed with the Securities and Exchange Commission, particularly those sections entitled "Factors Affecting Operating Results" and "Risk Factors" for a more complete discussion of these and other risks and uncertainties. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion